"Juno," replied the sire of gods and men, "you must not expect to be informed of all my counsels.
"Dread son of Saturn," answered Juno, "what are you talking about?
On this Juno was frightened, so she curbed her stubborn will and sat down in silence.
Juno smiled at this, and as she smiled she took the cup from her son's hands.
So Jove, the Olympian Lord of Thunder, hied him to the bed in which he always slept; and when he had got on to it he went to sleep, with Juno of the golden throne by his side.
Juno Markets has announced it has launched its company blog,
Juno Insights, focused on providing content ranging from trading psychology, industry secrets and forex education, the company said.
Jupitermay be over 365 million miles away from Earth, but thanks toNASA's
Juno spacecraft we're regularly given glimpses of its surface.
The Consul general of India to Dubai Vipul has confirmed missing Dubai-based expatriate,
Juno Srivastava was killed in the Easter Sunday blasts on April 21.
Pune, India, April 16, 2019 --(PR.com)-- The new "
JUNO Campus" comes packed with some extremely powerful features that students, faculty and management will find very useful.
Asteroid 3
Juno makes its closest approach to Earth at 8:00 UT (3:00 a.m.
- Shanghai-based clinical stage biopharmaceutical company JW Therapeutics has completed a USD 90m series A financing, where a consortium led by leading global investors Temasek, Sequoia Capital China, and YuanMing Capital is joined by a lineup of other investors, including Oriza Seed Capital, Yipu Capital, AVICT Global Holdings, and existing investors WuXi AppTec Group, and
Juno Therapeutics, the company said.
(NASDAQ: CELG) has closed its acquisition of cellular immunotherapy specialist
Juno Therapeutics, Inc.
Celgene Corporation (CELG) announced that its tender offer to purchase any and all issued and outstanding shares of common stock of
Juno Therapeutics (
JUNO) at a price of $87.00 per share, net to the seller in cash, without interest and less required withholding taxes, expired at 12:00 midnight Edo T, at the end of the day on Friday, March 2.The depositary for the tender offer has advised that, as of the expiration of the tender offer, a total of approximately 90,730,558 shares were validly tendered and not withdrawn in the tender offer, representing approximately 78% of
Juno's outstanding shares or approximately 88% of
Juno's outstanding shares including the
Juno shares already owned by Celgene.
